Indications of PD-1 Inhibitors for Advanced cSCC

Wednesday, April 14, 2021 at 4:00pm Pacific/5:00pm Central/ 7:00pm Eastern

Webinar will be 1 hour long.

The webinar will review the current data supporting the approvals for immune checkpoint inhibitors. Cases will be utilized to highlight the direct clinical application.

Learning Objective:

At the conclusion of the activity, participants will be able to:
Define the current approved indications for immune checkpoint inhibitors.

Moderator:

Kevin Emerick, MD, Massachusetts Eye & Ear Infirmary

Panelists:

Gina Jefferson, MD, MS, The University of Mississippi Medical Center

Miriam Lango, MD, MD Anderson Cancer Center

David Miller, MD, PhD, Massachusetts General Cancer Center

Matthew Witek, MD, MS, University of Maryland School of Medicine

REGISTER HERE

---

Past Instructional Courses

(click the banner to access the recording)

	AHNS Virtual Education Series: To Reconstruct or Not: Early Stage Oral Cavity Cancers presented February 23, 2021
	Multi-Disciplinary Approach to Advanced Oral Cancer: Prevention to Palliation Joint International Webinar presented February 5, 2021
	Update on the Unknown Primary: Diagnostic and Therapeutic Challenges presented January 13, 2021 (video available shortly)
	Management of Salivary Malignancy – Case Based Panel Discussion presented December 9, 2020
	Trends in Management of HPV Positive Cancers presented October 14, 2020